Drilldown: Medicines
Medicines > classes 
:
Cathinone or
Neuroleptic or
Selective 5HT2A inverse agonist (with weaker 5HT2C inverse agonism)
:
Cathinone or
Neuroleptic or
Selective 5HT2A inverse agonist (with weaker 5HT2C inverse agonism) Use the filters below to narrow your results.
generic:
None (1) ·
3-MMC (1) ·
Asenapine (1) ·
Butylone (1) ·
Cathinone (1) ·
Chlorpromazine (1) ·
Droperidol (1) ·
Ephylone (1) ·
Ethcathinone (1) ·
Ethylone (1) ·
Fluphenazine (1) ·
Hexedrone (1) ·
Iloperidone (1) ·
Loxapine (1) ·
Lurasidone (1) ·
Mephedrone (1) ·
Methcathinone (1) ·
Methylone (1) ·
Mexedrone (1) ·
Molindone (1) ·
N-Ethylhexedrone (1) ·
N-Ethylpentedrone (1) ·
Paliperidone (1) ·
Pentedrone (1) ·
Perphenazine (1) ·
Pimozide (1) ·
Thioridazine (1) ·
Thiothixene (1) ·
Trifluoperazine (1) ·
Ziprasidone (1)
brand:
None (14) ·
Fanapt (1) ·
Geodon (1) ·
Inapsine (1) ·
Invega (1) ·
Latuda (1) ·
Loxitane (1) ·
Mellaril (1) ·
Moban (1) ·
Navane (1) ·
Nuplazid (1) ·
Orap (1) ·
Prolixin (1) ·
Saphris (1) ·
Stelazine (1) ·
Thorazine (1) ·
Trilafon (1)
classes: (Click arrow to add another value)
mechanism:
Butyrophenone D2 antagonist (1) ·
Cathinone analogue; monoamine reuptake inhibitor (2) ·
D2 receptor antagonist; also H1, alpha-1, muscarinic antagonist (1) ·
D2/5-HT2A antagonist (1) ·
D2/5-HT2A antagonist; 5-HT7 antagonist (1) ·
D2/5-HT2A antagonist; active metabolite of risperidone (1) ·
D2/5-HT2A antagonist; SRI and NRI (1) ·
Dibenzoxazepine D2/5-HT2 antagonist (1) ·
Dihydroindolone D2 antagonist (1) ·
Diphenylbutylpiperidine D2 antagonist (1) ·
Monoamine releasing agent (4) ·
Monoamine releasing agent; active ingredient in khat (1) ·
Multi-receptor antagonist (D2, 5-HT2A, H1, alpha) (1) ·
Norepinephrine and dopamine releasing agent (1) ·
Norepinephrine/dopamine releasing agent (1) ·
Norepinephrine/dopamine reuptake inhibitor (1) ·
Phenothiazine D2 antagonist (4) ·
Selective inverse agonist at 5HT2A receptors with weaker activity at 5HT2C. Has no significant dopamine D2 affinity, unique among approved antipsychotics. Inverse agonism (rather than antagonism) reduces constitutive 5HT2A receptor activity below baseline. (1) ·
Serotonin releasing agent; monoamine reuptake inhibitor (1) ·
Serotonin/norepinephrine/dopamine releasing agent (3) ·
Thioxanthene D2 antagonist (1)
uses:
starting dose:
preparations:
fda max:
duration:
bioavailability:
pregnancy:
Showing below up to 30 results in range #1 to #30.